**Diagnostic Differential for Grok 4.6 Timeouts**

To isolate the failure mode without an expensive retry loop, execute a strict sequence of direct HTTP (zero-retry) probes, analyzing Time-to-First-Byte (TTFB) and HTTP status:

1.  **Endpoint/Auth vs. Provider Routing:** Send a minimal payload (e.g., "Ping") with a 5s deadline. Immediate 401/403 or failure to resolve indicates configuration. A 200 confirms auth and routing.
2.  **Retry Amplification:** Your Azure metrics show 499s (Client Closed Request). Send a moderate payload with a 55s timeout. If this yields a 504 or server-side timeout but *no* 499 in Azure, the prior 499s were artifacts of SDK-driven aggressive retry amplification dropping the connection prematurely.
3.  **Output-Reasoning-Cap Issue:** Send a prompt designed to trigger moderate reasoning but minimal text output (e.g., "Solve this complex logic puzzle and output ONLY the final digit"). Set `max_tokens` aggressively low. If this times out or yields a 499 after 55s, the provider's internal reasoning time is breaching the client deadline before emitting bytes.
4.  **Slow Provider:** If the low-token logic prompt returns successfully but TTFB is >45s, the provider is fundamentally too slow for a 55s deadline. The anomalous past success of large calls likely reflects favorable queue variance at that exact moment, not a structural payload advantage.

**Critique of the Expanded Astra Test Plan**

Your methodology for the Astra roster extraction is rigorous in isolating model capability from deterministic derivation. However, the experimental design has vulnerabilities:

*   **Substantive Gap 1: Deadline vs. Effort Mismatch.** You mandated a 120s deadline for Astra with a 4096 output cap. High-effort reasoning models frequently consume 60-90 seconds purely on internal chain-of-thought for dense 48-person tabular transcriptions before streaming the first output token. A 120s hard kill is highly likely to artificially truncate valid "medium/high effort" runs, conflating capability failure with latency clipping.
*   **Substantive Gap 2: Cost-Cap Rupture Risk.** You have a strict $4.90 headroom. Astra ($10/$50 per M) evaluating 7 papers (assuming ~15k input and 4k output tokens per paper) will cost ~$0.35 per run. Running low vs. medium effort variants across all papers doubles this. Adding Grok diagnostics risks breaching the $4.90 hard limit if token counts run higher or overhead bound is miscalculated.
*   **Substantive Gap 3: Weak Negative Constraints.** While you defined strict clinical exclusion logic (carrier != phenotype), the acceptance contract lacks a penalization structure for *hallucinated synthesis*. If a model merges an aggregate table with a narrative family to fabricate novel canonical rows that happen to yield the correct final derived integer, standard field-binding metrics might miss the provenance failure.

**Highest-Value Fixed Comparison**

Given the $4.90 budget, do not run all 6-7 papers across multiple effort tiers. Instead, execute a **2x2 fixed ablation on exactly two maximally divergent papers**:
1.  The 48-person merged DOC (tests tabular density, extraction scaling, and row provenance).
2.  The 8-person narrative family (tests clinical logic, baseline vs. follow-up distinction, and exclusion).

Run these two papers through Astra (Low Effort) vs. Astra (Medium Effort) to establish the delta.

**Tractable Acceptance Contract**

To prevent spurious certification where gold integers agree by coincidence, enforce a **Bipartite Provenance Contract**:
1.  **Entity Grounding:** Every extracted row must quote the literal source text justifying the phenotype binding.
2.  **Pathological Rejection:** The model must explicitly output a "dropped" array for entities mentioned (e.g., asymptomatic carriers, healthy controls) with the specific clinical rule invoked to exclude them. Validation passes only if both the inclusions and explicit rejections align with the reference.
